The U.S. government is seeking thousands of volunteers, from babies to the elderly, to roll up their sleeves for the first clinical trials of an H1N1 flu vaccine. The race is on to test whether a new vaccine really will protect against this virus before its expected rebound in the fall. Will the vaccines work? Will there be enough vaccines for everyone? What are the dangers of the vaccine itself? The Takeaway talks to Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, which will oversee the trials.
The story you just read is freely available and accessible to everyone because readers like you support The World financially.
Thank you all for helping us reach our goal of 1,000 donors. We couldn’t have done it without your support. Your donation directly supported the critical reporting you rely on, the consistent reporting you believe in, and the deep reporting you want to ensure survives.